Metabolism of clofazimine in leprosy patients.
Article Details
- CitationCopy to clipboard
Feng PC, Fenselau CC, Jacobson RR
Metabolism of clofazimine in leprosy patients.
Drug Metab Dispos. 1981 Nov-Dec;9(6):521-4.
- PubMed ID
- 6120809 [ View in PubMed]
- Abstract
We have identified two metabolites of clofazimine (B663; Lamprene; 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-isopropyliminophenazine) in our initial investigation of its metabolism in leprosy patients. Based on mass, ultraviolet, and visible spectrometry, we characterized an unconjugated (metabolite I, 3-(p-hydroxyanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-isopropyliminophenazine ) and a conjugated (metabolite II, 3-(beta-D-glucopyranosiduronic acid)-10-(p-chlorophenyl)-2,10-dihydro-2-isopropyliminophenazine) metabolite from the urine of patients. Both metabolites were red in color, similar to clofazimine; however, both were considerably more polar than the parent drug. We suggest that metabolite I was formed by a hydrolytic dehalogenation reaction, and metabolite II by hydrolytic deamination followed by glucuronidation.
DrugBank Data that Cites this Article
- Drugs